Alamar Biosciences, Inc. Net Fee Amt
Alamar Biosciences, Inc. (ALMR) had Net Fee Amt of $22.56 thousand as of 2026-04-20, per its S-8 filed 2026-04-20.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-04-20
- 2026-04-20: Net Fee Amt $22.56K.
- 2026-04-16: Net Fee Amt $5.06K.
- 2026-04-09: Net Fee Amt $25.31K.
| Period end | Net Fee Amt |
|---|---|
| 2026-04-20 | $22.56K S-8 · filed 2026-04-20 |
| 2026-04-16 | $5.06K S-1MEF · filed 2026-04-16 |
| 2026-04-09 | $25.31K S-1/A · filed 2026-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |